Chest · 2003
Legionnaires disease and HIV infection.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pedro-Botet Maria Luisa, Sabrià Miquel, Sopena Nieves, García-Núñez Marian, Dominguez María Jesús, Reynaga Esteban, Rey-Joly Celestino
Аннотация
STUDY OBJECTIVES: To compare the outcome of Legionnaires disease (LD) in patients with and without HIV infection.
DESIGN: Retrospective review of clinical charts.
SETTING: Six hundred-bed university hospital.
PATIENTS: We studied the clinical findings of 64 patients without HIV and 15 patients with HIV. Patients with a serologic diagnosis only were not included. Patients with previous immunosuppressive therapy or transplant recipients were excluded from the former group. In the HIV group, the mean CD4 cell count was 347.5/ microL, plasma viral load was undetectable in 50% of the patients, and only one patient (7%) was receiving cotrimoxazole as prophylaxis against Pneumocystis carinii at the time of pneumonia. No differences were observed in the two groups with respect to community or nosocomial acquisition, delay in the initiation of appropriate treatment, the use of macrolides or fluoroquinolones, and Fine score in cases of community-acquired LD.
RESULTS: Univariate analysis showed that time to apyrexia was longer, and respiratory symptoms, bilateral infiltrates in chest radiograph, hyponatremia, increase in aspartate aminotransferase and creatine phosphokinase (CK), and respiratory failure were more frequent in the HIV group. Mortality was greater in patients with HIV, achieving a statistically significant value of 20%; however, multivariate analysis only confirmed these differences with respect to the increase in CK.
CONCLUSIONS: LD has a more severe clinical presentation and worse evolution in patients with HIV.
DESIGN: Retrospective review of clinical charts.
SETTING: Six hundred-bed university hospital.
PATIENTS: We studied the clinical findings of 64 patients without HIV and 15 patients with HIV. Patients with a serologic diagnosis only were not included. Patients with previous immunosuppressive therapy or transplant recipients were excluded from the former group. In the HIV group, the mean CD4 cell count was 347.5/ microL, plasma viral load was undetectable in 50% of the patients, and only one patient (7%) was receiving cotrimoxazole as prophylaxis against Pneumocystis carinii at the time of pneumonia. No differences were observed in the two groups with respect to community or nosocomial acquisition, delay in the initiation of appropriate treatment, the use of macrolides or fluoroquinolones, and Fine score in cases of community-acquired LD.
RESULTS: Univariate analysis showed that time to apyrexia was longer, and respiratory symptoms, bilateral infiltrates in chest radiograph, hyponatremia, increase in aspartate aminotransferase and creatine phosphokinase (CK), and respiratory failure were more frequent in the HIV group. Mortality was greater in patients with HIV, achieving a statistically significant value of 20%; however, multivariate analysis only confirmed these differences with respect to the increase in CK.
CONCLUSIONS: LD has a more severe clinical presentation and worse evolution in patients with HIV.
Предметные рубрики MeSH
AIDS-Related Opportunistic InfectionsAdultAgedAged, 80 and overAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountFemaleHIV InfectionsHumansLegionnaires' DiseaseMaleMedical RecordsMiddle AgedPneumonia, PneumocystisRetrospective StudiesRisk FactorsTreatment OutcomeTrimethoprim, Sulfamethoxazole Drug CombinationViral Load